MODERATE HEMOPHILIA A

Clinical trials for MODERATE HEMOPHILIA A explained in plain language.

Never miss a new study

Get alerted when new MODERATE HEMOPHILIA A trials appear

Sign up with your email to follow new studies for MODERATE HEMOPHILIA A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Can a new hemophilia drug protect Patients' joints and boost activity?

Disease control Ongoing

This study is checking if a preventive treatment called emicizumab helps protect joints and allows for more physical activity in teens and adults with moderate to severe hemophilia A. It will follow 136 participants for up to 3 years, using ultrasounds, activity trackers, and que…

Matched conditions: MODERATE HEMOPHILIA A

Phase: PHASE4 • Sponsor: Hoffmann-La Roche • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

MODERATE HEMOPHILIA A

Get alerted when new MODERATE HEMOPHILIA A trials appear

Can a new hemophilia drug protect Patients' joints and boost activity?